ASEAN Point of Care Diagnostics Market by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), Technology (Lateral Flow Assays, Biochemistry, MDx), End User (Home Care, Hospitals) - Forecast to 2030

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Key Stakeholders
1.5 Summary of Changes

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Secondary Sources
2.1.1.2 Key Data from Secondary Sources
2.1.1.3 Key Objectives
2.1.2 Primary Data
2.1.2.1 Key Primary Sources
2.1.2.2 Key Data from Primary Sources
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.1.1 Company Revenue Estimation Approach
2.2.1.2 Presentations of Companies & Primary Interviews
2.2.1.3 Growth Forecast
2.2.1.4 CAGR Projections
2.2.2 Top-Down Approach
2.3 Data Triangulation
2.4 Market Share Analysis
2.5 Research Assumptions
2.5.1 Growth Rate Assumptions
2.6 Research Limitations
2.7 Risk Assessment

4.1 Asean Point of Care Diagnostics Market Overview
4.2 Asean Point of Care Diagnostics Market, by Product, 2025 vs. 2030
4.3 Asean Point of Care Diagnostics Market, by Technology, 2025 vs. 2030
4.4 Asean Point of Care Diagnostics Market, by End-user, 2025 vs. 2030
4.5 Asean Point of Care Diagnostics Market: Geographic Growth Opportunities

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence of Infectious Diseases
5.2.1.2 Increasing Prevalence of Chronic Diseases
5.2.1.3 Favorable Government Initiatives for Poc Testing
5.2.1.4 Rising Number of Public-Private Partnerships (Ppps)
5.2.2 Restraints
5.2.2.1 Pricing Pressure on Manufacturers
5.2.2.2 Stringent Regulatory Approval Process for Product Commercialization
5.2.3 Opportunities
5.2.3.1 Gradual Shift Toward Decentralized Healthcare Systems
5.2.3.2 Availability of Poc Tests with Multiplexing Capabilities
5.2.4 Challenges
5.2.4.1 Shortage of Skilled Healthcare Providers
5.2.4.2 Premium Pricing of Novel Platforms
5.3 Trends/Disruptions Impacting Customers’ Businesses
5.4 Pricing Analysis
5.4.1 Indicative Selling Price Trend of Poc Tests, by Product
5.4.2 Indicative Selling Price Trend of Glucose Test Strips, by Key Player
5.4.3 Indicative Selling Price Trend of Poc Pregnancy Test Kits, by Country
5.5 Value Chain Analysis
5.6 Supply Chain Analysis
5.7 Ecosystem Analysis
5.8 Investment & Funding Scenario
5.9 Technology Analysis
5.9.1 Key Technologies
5.9.1.1 Lateral Flow Assays
5.9.2 Complementary Technologies
5.9.2.1 Molecular Diagnostics
5.9.3 Adjacent Technologies
5.9.3.1 Biochemical Technologies
5.10 Patent Analysis
5.11 Trade Analysis
5.11.1 Import Data for HS Code 3822
5.11.2 Export Data for HS Code 3822
5.12 Key Conferences & Events, 2025-2026
5.13 Regulatory Analysis
5.13.1 Regulatory Landscape
5.13.1.1 Vietnam
5.13.1.2 Laos
5.13.1.3 Cambodia
5.13.1.4 Malaysia
5.13.1.5 Myanmar
5.13.1.6 Philippines
5.13.1.7 Singapore
5.13.1.8 Thailand
5.13.1.9 Indonesia
5.13.1.10 Brunei
5.13.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.14 Porter's Five Forces Analysis
5.14.1 Threat of New Entrants
5.14.2 Threat of Substitutes
5.14.3 Bargaining Power of Buyers
5.14.4 Bargaining Power of Suppliers
5.14.5 Intensity of Competitive Rivalry
5.15 Key Stakeholders & Buying Criteria
5.15.1 Key Stakeholders in Buying Process
5.15.2 Key Buying Criteria
5.16 Impact of AI on Asean Point of Care Diagnostics Market
5.16.1 Introduction
5.16.2 Market Potential of AI in Poc Diagnostic Applications
5.16.3 AI Use Cases
5.16.4 Key Companies Implementing AI
5.16.5 Future of AI in Asean Point of Care Diagnostics Market

6.1 Introduction
6.2 Glucose Monitoring Products
6.2.1 Glucometers
6.2.1.1 Accurate Monitoring of Blood Sugar Levels to Drive Market
6.2.2 Glucose Test Strips
6.2.2.1 Increasing Uptake of Single-Use Products to Fuel Market
6.2.3 Lancets
6.2.3.1 Increasing Preference for Home-based Care to Support Market Growth
6.3 Infectious Disease Testing Products
6.3.1 Respiratory Infection Testing Products
6.3.1.1 Tb Testing Products
6.3.1.1.1 High Prevalence of Tuberculosis Cases to Fuel Market
6.3.1.2 Influenza Testing Products
6.3.1.2.1 Rising Need for Targeted Treatment Therapies to Boost Demand
6.3.1.3 Other Respiratory Infection Testing Products
6.3.2 Mosquito-Borne Disease Testing Products
6.3.2.1 Rising Incidence of Malaria & Dengue to Boost Demand
6.3.3 Std Testing Products
6.3.3.1 Need to Reduce Disease Transmission Rates to Facilitate Growth
6.3.4 HIV Testing Products
6.3.4.1 Growing Awareness of HIV Poc Testing to Boost Demand
6.3.5 Hai Testing Products
6.3.5.1 Growing Incidence of Hais in Healthcare Settings to Drive Market
6.3.6 Hepatitis Testing Products
6.3.6.1 Hepatitis B Testing Products
6.3.6.1.1 Increasing Prevalence of Liver Infections to Fuel Market
6.3.6.2 Hepatitis C Testing Products
6.3.6.2.1 Rising Need to Combat Hepatitis Among High-Risk Subgroups to Support Market Growth
6.3.7 Other Infectious Disease Testing Products
6.4 COVID-19 Testing Products
6.4.1 Gradual Shift Towards Syndromic Testing to Support Market Growth
6.5 Cardiometabolic Testing Products
6.5.1 Cardiac Marker Testing Products
6.5.1.1 Early Detection of Myocardial Infarctions and Acute Coronary Syndromes to Fuel Market
6.5.2 Hba1C Testing Products
6.5.2.1 Provision of Long-Term Measurement in Blood Glucose Control to Boost Demand
6.5.3 Blood Gas & Electrolyte Testing Products
6.5.3.1 Monitoring of Key Parameters for Ph and Oxygen Saturation to Drive Market
6.6 Coagulation Monitoring Products
6.6.1 High Incidence of Bleeding Disorders to Fuel Uptake
6.7 Pregnancy & Fertility Testing Products
6.7.1 Growing Awareness of Sustainable Family Planning to Propel Market
6.8 Hematology Testing Products
6.8.1 Rising Demand for Blood Transfusion Procedures to Drive Market
6.9 Cancer Marker Testing Products
6.9.1 Increasing Preference for Personalized Oncology Therapeutics to Propel Market
6.10 Fecal Occult Testing Products
6.10.1 Favorable Initiatives for Colorectal Cancer Screening to Boost Market
6.11 Cholesterol Testing Products
6.11.1 Rising Obesity Rate Caused by Sedentary Lifestyles to Drive Market
6.12 Urinalysis Testing Products
6.12.1 Rising Prevalence of Utis and Kidney Diseases to Drive Market
6.13 Drugs-Of-Abuse Testing Products
6.13.1 High Consumption of Illicit Drugs to Fuel Market
6.14 Other Poc Products

7.1 Introduction
7.2 Biochemistry
7.2.1 Provision of Rapid Onsite Results for Chronic Conditions to Drive Market
7.3 Lateral Flow Assays (Immunoassays)
7.3.1 Integration of Elisa into Disposable Testing Strips for Complex Laboratory Analysis to Fuel Market
7.4 Rapid Tests (Molecular Diagnostics)
7.4.1 Analysis of Biological Markers for Rapid Disease Detection to Propel Market

8.1 Introduction
8.2 Home Care Settings
8.2.1 Growing Consumer Preference for Convenience and Affordability to Propel Market
8.3 Clinical Laboratories
8.3.1 Management of High Patient Volumes with Automated Testing Solutions to Fuel Market
8.4 Hospitals and Critical Care Centers
8.4.1 Rising Requirement for Rapid Poc Testing in Emergency Use to Support Market Growth
8.5 Outpatient Settings and Ambulatory Care Centers
8.5.1 Cost-Effectiveness Over Hospitals to Boost Market Growth
8.6 Other End-users

9.1 Introduction
9.1.1 Macroeconomic Outlook for Asean Countries
9.2 Indonesia
9.2.1 Rising Public Awareness About Preventive Healthcare to Drive Market
9.2.2 Macroeconomic Outlook for Indonesia
9.3 Thailand
9.3.1 Expanding Geriatric Population and Subsequent Rise in Chronic Diseases to Fuel Market
9.3.2 Macroeconomic Outlook for Thailand
9.4 Malaysia
9.4.1 High Incidence of Diabetes to Boost Demand
9.4.2 Macroeconomic Outlook for Malaysia
9.5 Philippines
9.5.1 Improved Healthcare Access and Insurance Coverage to Fuel Adoption
9.5.2 Macroeconomic Outlook for Philippines
9.6 Vietnam
9.6.1 Improving Healthcare Infrastructure and Favorable Government Initiatives to Propel Market
9.6.2 Macroeconomic Outlook for Vietnam
9.7 Singapore
9.7.1 Increasing Demand for Specialized Medical Services to Boost Market
9.7.2 Macroeconomic Outlook for Singapore
9.8 Myanmar
9.8.1 Rising Need for Affordable Diagnostic Solutions to Drive Market
9.8.2 Macroeconomic Outlook for Myanmar
9.9 Cambodia
9.9.1 Rising Prevalence of Ncds to Support Market Growth
9.9.2 Macroeconomic Outlook for Cambodia
9.10 Laos
9.10.1 Need for Decentralized Diagnostic Solutions to Fuel Demand
9.10.2 Macroeconomic Outlook for Laos
9.11 Brunei
9.11.1 Growing Need for Cost-Effective Poc Solutions to Fuel Market
9.11.2 Macroeconomic Outlook for Brunei

10.1 Introduction
10.2 Key Player Strategies/Right to Win
10.2.1 Overview of Strategies Adopted by Players in Asean Point of Care Diagnostics Market
10.3 Revenue Analysis, 2022-2024
10.4 Market Share Analysis, 2024
10.5 Company Evaluation Matrix: Key Players, 2024
10.5.1 Stars
10.5.2 Emerging Leaders
10.5.3 Pervasive Players
10.5.4 Participants
10.5.5 Company Footprint, Key Players, 2024
10.5.5.1 Company Footprint
10.5.5.2 Country Footprint
10.5.5.3 Product Footprint
10.5.5.4 Technology Footprint
10.6 Company Evaluation Matrix: Startups/SMEs, 2024
10.6.1 Progressive Companies
10.6.2 Responsive Companies
10.6.3 Dynamic Companies
10.6.4 Starting Blocks
10.6.5 Competitive Benchmarking: Startups/SMEs, 2024
10.6.5.1 Detailed List of Key Startups/SMEs
10.6.5.2 Competitive Benchmarking of Key Startups/SMEs, by Technology
10.6.5.3 Competitive Benchmarking of Key Startups/SMEs, by Country
10.7 Company Valuation & Financial Metrics
10.7.1 Financial Metrics
10.7.2 Company Valuation
10.8 Brand/Product Comparison
10.9 Competitive Scenario
10.9.1 Product Launches & Approvals
10.9.2 Deals
10.9.3 Expansions

11.1 Key Players
11.1.1 Abbott
11.1.1.1 Business Overview
11.1.1.2 Products Offered
11.1.1.3 Recent Developments
11.1.1.3.1 Product Approvals
11.1.1.3.2 Deals
11.1.1.4 Analyst's View
11.1.1.4.1 Key Strengths
11.1.1.4.2 Strategic Choices
11.1.1.4.3 Weaknesses & Competitive Threats
11.1.2 F. Hoffmann-La Roche Ltd.
11.1.2.1 Business Overview
11.1.2.2 Products Offered
11.1.2.3 Recent Developments
11.1.2.3.1 Product Launches & Approvals
11.1.2.3.2 Deals
11.1.2.4 Analyst's View
11.1.2.4.1 Key Strengths
11.1.2.4.2 Strategic Choices
11.1.2.4.3 Weaknesses & Competitive Threats
11.1.3 Siemens Healthineers AG
11.1.3.1 Business Overview
11.1.3.2 Products Offered
11.1.3.3 Recent Developments
11.1.3.3.1 Product Approvals
11.1.3.3.2 Deals
11.1.3.3.3 Expansions
11.1.3.4 Analyst's View
11.1.3.4.1 Key Strengths
11.1.3.4.2 Strategic Choices
11.1.3.4.3 Weaknesses & Competitive Threats
11.1.4 Sysmex Corporation
11.1.4.1 Business Overview
11.1.4.2 Products Offered
11.1.4.3 Recent Developments
11.1.4.3.1 Expansions
11.1.4.4 Analyst's View
11.1.4.4.1 Key Strengths
11.1.4.4.2 Strategic Choices
11.1.4.4.3 Weaknesses & Competitive Threats
11.1.5 Danaher Corporation
11.1.5.1 Business Overview
11.1.5.2 Products Offered
11.1.5.3 Analyst's View
11.1.5.3.1 Key Strengths
11.1.5.3.2 Strategic Choices
11.1.5.3.3 Weaknesses and Competitive Threats
11.1.6 Bd
11.1.6.1 Business Overview
11.1.6.2 Products Offered
11.1.6.3 Recent Developments
11.1.6.3.1 Deals
11.1.6.3.2 Expansions
11.1.7 Quidelortho Corporation
11.1.7.1 Business Overview
11.1.7.2 Recent Developments
11.1.7.2.1 Product Approvals
11.1.7.2.2 Deals
11.1.7.2.3 Expansions
11.1.8 Cardinal Health
11.1.8.1 Business Overview
11.1.8.2 Products Offered
11.1.8.3 Recent Developments
11.1.8.3.1 Deals
11.1.8.3.2 Expansions
11.1.9 Biomérieux
11.1.9.1 Business Overview
11.1.9.2 Products Offered
11.1.9.3 Recent Developments
11.1.9.3.1 Product Approvals
11.1.9.3.2 Deals
11.1.10 Ekf Diagnostics Holdings PLC
11.1.10.1 Business Overview
11.1.10.2 Products Offered
11.1.10.3 Recent Developments
11.1.10.3.1 Product Launches
11.1.10.3.2 Deals
11.1.10.3.3 Expansions
11.1.11 Thermo Fisher Scientific Inc.
11.1.11.1 Business Overview
11.1.11.2 Products Offered
11.1.11.3 Recent Developments
11.1.11.3.1 Product Launches
11.1.11.3.2 Deals
11.1.12 Accubiotech, Co. Ltd.
11.1.12.1 Business Overview
11.1.12.2 Products Offered
11.1.12.3 Recent Developments
11.1.12.3.1 Product Approvals
11.2 Other Players
11.2.1 Biosynex SA
11.2.2 Sd Biosensor, Inc.
11.2.3 Sekisui Diagnostics
11.2.4 Werfen
11.2.5 Trinity Biotech
11.2.6 Pts Diagnostics
11.2.7 Lifescan IP Holdings, LLC
11.2.8 Ctk Biotech, Inc.
11.2.9 Wondfo
11.2.10 Arkray, Inc.
11.2.11 Xiamen Boson Biotech Co. Ltd.
11.2.12 Credo Diagnostics Biomedical Pte. Ltd.
11.2.13 Anbio Biotechnology Inc.
11.2.14 Sg Diagnostics

12.1 Discussion Guide
12.2 Knowledgestore: The Subscription Portal
12.3 Available Customizations

Table 1 Asean Point of Care Diagnostics Market: Key Data from Primary Sources
Table 2 Asean Point of Care Diagnostics Market: Risk Assessment Analysis
Table 3 Hepatitis Disease Burden and Deaths Caused by Hepatitis, by Country (2022)
Table 4 Diabetes Estimates (Ages 20-79) and Diabetes-Related Deaths, by Country, 2021
Table 5 Projected Increase in Cancer Patients, by Country, 2022 vs. 2035 vs. 2045
Table 6 Indicative Selling Price Trend of Poc Tests, by Product, 2023-2025
Table 7 Indicative Selling Price Trend of Glucose Test Strips, by Key Player, 2023-2025
Table 8 Indicative Selling Price Trend of Poc Pregnancy Test Kits, by Country, 2023-2025
Table 9 Asean Point of Care Diagnostics Market: Role in Ecosystem
Table 10 Asean Point of Care Diagnostics Market: Innovations & Patent Registrations, 2022-2024
Table 11 Import Data for Diagnostic & Laboratory Reagents (HS Code 3822), by Country, 2020-2024 (USD Thousand)
Table 12 Export Data for Diagnostic & Laboratory Reagents (HS Code 3822), by Country, 2020-2024 (USD Thousand)
Table 13 Asean Poc Diagnostics Market: Key Conferences & Events, 2025-2026
Table 14 Malaysia: Classification of Ivd Medical Devices
Table 15 Myanmar: Classification of Ivd Medical Devices
Table 16 Asean Countries: Key Regulatory Bodies, Government Agencies, and Other Organizations
Table 17 Asean Point of Care Diagnostics Market: Porter's Five Forces Analysis
Table 18 Influence of Stakeholders on Buying Process, by Technology (%)
Table 19 Key Buying Criteria, by Technology
Table 20 Asean Point of Care Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 21 Diabetes Prevalence (20-79 Yrs), Diabetes-Related Deaths, and Proportion of Undiagnosed Diabetes, by Country, 2021
Table 22 Asean Point of Care Diagnostics Market for Glucose Monitoring Products, by Type, 2022-2030 (USD Million)
Table 23 Asean Point of Care Diagnostics Market for Glucose Monitoring Products, by Country, 2022-2030 (USD Million)
Table 24 Glucometers: Currently Available Products, by Company
Table 25 Asean Point of Care Diagnostics Market for Glucometers, by Country, 2022-2030 (USD Million)
Table 26 Glucose Test Strips: Currently Available Products, by Company
Table 27 Asean Point of Care Diagnostics Market for Glucose Test Strips, by Country, 2022-2030 (USD Million)
Table 28 Lancets & Lancing Devices: Currently Available Products, by Company
Table 29 Asean Point of Care Diagnostics Market for Lancets, by Country, 2022-2030 (USD Million)
Table 30 Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Disease Type, 2022-2030 (USD Million)
Table 31 Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Country, 2022-2030 (USD Million)
Table 32 Asean Point of Care Diagnostics Market for Respiratory Infection Testing Products, by Type, 2022-2030 (USD Million)
Table 33 Asean Point of Care Diagnostics Market for Respiratory Infection Testing Products, by Country, 2022-2030 (USD Million)
Table 34 Tb Testing: Currently Available Products, by Company
Table 35 Asean Point of Care Diagnostics Market for Tb Testing Products, by Country, 2022-2030 (USD Million)
Table 36 Influenza Testing: Currently Available Products, by Company
Table 37 Asean Point of Care Diagnostics Market for Influenza Testing Products, by Country, 2022-2030 (USD Million)
Table 38 Other Respiratory Infection Testing: Currently Available Products, by Company
Table 39 Asean Point of Care Diagnostics Market for Other Respiratory Infection Testing Products, by Country, 2022-2030 (USD Million)
Table 40 Mosquito-Borne Disease Testing: Currently Available Products, by Company
Table 41 Asean Point of Care Diagnostics Market for Mosquito-Borne Disease Testing Products, by Country, 2022-2030 (USD Million)
Table 42 Std Testing: Currently Available Products, by Company
Table 43 Asean Point of Care Diagnostics Market for Std Testing Products, by Country, 2022-2030 (USD Million)
Table 44 HIV Testing: Currently Available Products, by Company
Table 45 Asean Point of Care Diagnostics Market for HIV Testing Products, by Country, 2022-2030 (USD Million)
Table 46 Hai Testing: Currently Available Products, by Company
Table 47 Asean Point of Care Diagnostics Market for Hai Testing Products, by Country, 2022-2030 (USD Million)
Table 48 Asean Point of Care Diagnostics Market for Hepatitis Testing Products, by Type, 2022-2030 (USD Million)
Table 49 Asean Point of Care Diagnostics Market for Hepatitis Testing Products, by Country, 2022-2030 (USD Million)
Table 50 Hepatitis B Testing: Currently Available Products, by Company
Table 51 Asean Point of Care Diagnostics Market for Hepatitis B Testing Products, by Country, 2022-2030 (USD Million)
Table 52 Hepatitis C Testing: Currently Available Products, by Company
Table 53 Asean Point of Care Diagnostics Market for Hepatitis C Testing Products, by Country, 2022-2030 (USD Million)
Table 54 Other Infectious Disease Testing: Currently Available Products, by Company
Table 55 Asean Point of Care Diagnostics Market for Other Infectious Disease Testing Products, by Country, 2022-2030 (USD Million)
Table 56 Asean Point of Care Diagnostics Market for COVID-19 Testing Products, by Country, 2022-2030 (USD Million)
Table 57 Cardiometabolic Testing: Currently Available Products, by Company
Table 58 Asean Point of Care Diagnostics Market for Cardiometabolic Testing Products, by Type, 2022-2030 (USD Million)
Table 59 Asean Point of Care Diagnostics Market for Cardiometabolic Testing Products, by Country, 2022-2030 (USD Million)
Table 60 Asean Point of Care Diagnostics Market for Cardiac Marker Testing Products, by Country, 2022-2030 (USD Million)
Table 61 Asean Point of Care Diagnostics Market for Hba1C Testing Products, by Country, 2022-2030 (USD Million)
Table 62 Asean Point of Care Diagnostics Market for Blood Gas & Electrolyte Testing Products, by Country, 2022-2030 (USD Million)
Table 63 Coagulation Monitoring: Currently Available Products, by Company
Table 64 Asean Point of Care Diagnostics Market for Coagulation Monitoring Products, by Country, 2022-2030 (USD Million)
Table 65 Pregnancy & Fertility Testing: Currently Available Products, by Company
Table 66 Asean Point of Care Diagnostics Market for Pregnancy & Fertility Testing Products, by Country, 2022-2030 (USD Million)
Table 67 Asean Point of Care Diagnostics Market: Total Number of Pregnancies, by Country, 2022-2030 (In Million)
Table 68 Hematology Testing: Currently Available Products, by Company
Table 69 Asean Point of Care Diagnostics Market for Hematology Testing Products, by Country, 2022-2030 (USD Million)
Table 70 Number of Cases for Top Five Cancer Types, 2022
Table 71 Cancer Marker Testing: Currently Available Products, by Company
Table 72 Asean Point of Care Diagnostics Market of Cancer Marker Testing Products, by Country, 2022-2030 (USD Million)
Table 73 Estimated Number of New Cases of Colorectal Cancer, 2022 vs. 2035 vs. 2045
Table 74 Fecal Occult Blood Testing: Currently Available Products, by Company
Table 75 Asean Point of Care Diagnostics Market for Fecal Occult Blood Testing Products, by Country, 2022-2030 (USD Million)
Table 76 Cholesterol Testing Products: Currently Available Products, by Company
Table 77 Asean Point of Care Diagnostics Market for Cholesterol Testing Products, by Country, 2022-2030 (USD Million)
Table 78 Urinalysis Testing: Currently Available Products, by Company
Table 79 Asean Point of Care Diagnostics Market for Urinalysis Testing Products, by Country, 2022-2030 (USD Million)
Table 80 Drugs-Of-Abuse Testing: Currently Available Products, by Company
Table 81 Asean Point of Care Diagnostics Market for Drugs-Of-Abuse Testing Products, by Country, 2022-2030 (USD Million)
Table 82 Other Poc Products: Currently Available Products, by Company
Table 83 Asean Point of Care Diagnostics Market for Other Poc Products, by Country, 2022-2030 (USD Million)
Table 84 Asean Point of Care Diagnostics Market, by Technology, 2022-2030 (USD Million)
Table 85 Biochemistry: Currently Available Products, by Company
Table 86 Asean Point of Care Diagnostics Market for Biochemistry, by Country, 2022-2030 (USD Million)
Table 87 Lateral Flow Assays: Currently Available Products, by Company
Table 88 Asean Point of Care Diagnostics Market for Lateral Flow Assays (Immunoassays), by Country, 2022-2030 (USD Million)
Table 89 Asean Point of Care Diagnostics Market for Rapid Tests (Molecular Diagnostics), by Country, 2022-2030 (USD Million)
Table 90 Asean Point of Care Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 91 Asean Point of Care Diagnostics Market for Home Care Settings, by Country, 2022-2030 (USD Million)
Table 92 Asean Point of Care Diagnostics Market for Clinical Laboratories, by Country, 2022-2030 (USD Million)
Table 93 Asean Point of Care Diagnostics Market for Hospitals and Critical Care Centers, by Country, 2022-2030 (USD Million)
Table 94 Asean Point of Care Diagnostics Market for Outpatient Settings and Ambulatory Care Centers, by Country, 2022-2030 (USD Million)
Table 95 Asean Point of Care Diagnostics Market for Other End-users, by Country, 2022-2030 (USD Million)
Table 96 Asean Point of Care Diagnostics Market, by Country, 2022-2030 (USD Million)
Table 97 Indonesia: Macroeconomic Indicators for Asean Point of Care Diagnostics Market
Table 98 Indonesia: Asean Point of Care Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 99 Indonesia: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Disease Type, 2022-2030 (USD Million)
Table 100 Indonesia: Asean Point of Care Diagnostics Market for Respiratory Infection Testing Products, by Type, 2022-2030 (USD Million)
Table 101 Indonesia: Asean Point of Care Diagnostics Market for Hepatitis Testing Products, by Type, 2022-2030 (USD Million)
Table 102 Indonesia: Asean Point of Care Diagnostics Market for Glucose Monitoring Products, by Type, 2022-2030 (USD Million)
Table 103 Indonesia: Asean Point of Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2022-2030 (USD Million)
Table 104 Indonesia: Asean Point of Care Diagnostics Market, by Technology, 2022-2030 (USD Million)
Table 105 Indonesia: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Technology, 2022-2030 (USD Million)
Table 106 Indonesia: Asean Point of Care Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 107 Thailand: Macroeconomic Indicators for Asean Point of Care Diagnostics Market
Table 108 Thailand: Asean Point of Care Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 109 Thailand: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Disease Type, 2022-2030 (USD Million)
Table 110 Thailand: Asean Point of Care Diagnostics Market for Respiratory Infection Testing Products, by Type, 2022-2030 (USD Million)
Table 111 Thailand: Asean Point of Care Diagnostics Market for Hepatitis Testing Products, by Type, 2022-2030 (USD Million)
Table 112 Thailand: Asean Point of Care Diagnostics Market for Glucose Monitoring Products, by Type, 2022-2030 (USD Million)
Table 113 Thailand: Asean Point of Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2022-2030 (USD Million)
Table 114 Thailand: Asean Point of Care Diagnostics Market, by Technology, 2022-2030 (USD Million)
Table 115 Thailand: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Technology, 2022-2030 (USD Million)
Table 116 Thailand: Asean Point of Care Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 117 Malaysia: Macroeconomic Indicators for Asean Point of Care Diagnostics Market
Table 118 Malaysia: Asean Point of Care Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 119 Malaysia: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Disease Type, 2022-2030 (USD Million)
Table 120 Malaysia: Asean Point of Care Diagnostics Market for Respiratory Infection Testing Products, by Type, 2022-2030 (USD Million)
Table 121 Malaysia: Asean Point of Care Diagnostics Market for Hepatitis Testing Products, by Type, 2022-2030 (USD Million)
Table 122 Malaysia: Asean Point of Care Diagnostics Market for Glucose Monitoring Products, by Type, 2022-2030 (USD Million)
Table 123 Malaysia: Asean Point of Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2022-2030 (USD Million)
Table 124 Malaysia: Asean Point of Care Diagnostics Market, by Technology, 2022-2030 (USD Million)
Table 125 Malaysia: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Technology, 2022-2030 (USD Million)
Table 126 Malaysia: Asean Point of Care Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 127 Philippines: Macroeconomic Indicators for Asean Point of Care Diagnostics Market
Table 128 Philippines: Asean Point of Care Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 129 Philippines: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Disease Type, 2022-2030 (USD Million)
Table 130 Philippines: Asean Point of Care Diagnostics Market for Respiratory Infection Testing Products, by Type, 2022-2030 (USD Million)
Table 131 Philippines: Asean Point of Care Diagnostics Market for Hepatitis Testing Products, by Type, 2022-2030 (USD Million)
Table 132 Philippines: Asean Point of Care Diagnostics Market for Glucose Monitoring Products, by Type, 2022-2030 (USD Million)
Table 133 Philippines: Asean Point of Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2022-2030 (USD Million)
Table 134 Philippines: Asean Point of Care Diagnostics Market, by Technology, 2022-2030 (USD Million)
Table 135 Philippines: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Technology, 2022-2030 (USD Million)
Table 136 Philippines: Asean Point of Care Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 137 Vietnam: Macroeconomic Indicators for Asean Point of Care Diagnostics Market
Table 138 Vietnam: Asean Point of Care Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 139 Vietnam: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Disease Type, 2022-2030 (USD Million)
Table 140 Vietnam: Asean Point of Care Diagnostics Market for Respiratory Infection Testing Products, by Type, 2022-2030 (USD Million)
Table 141 Vietnam: Asean Point of Care Diagnostics Market for Hepatitis Testing Products, by Type, 2022-2030 (USD Million)
Table 142 Vietnam: Asean Point of Care Diagnostics Market for Glucose Monitoring Products, by Type, 2022-2030 (USD Million)
Table 143 Vietnam: Asean Point of Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2022-2030 (USD Million)
Table 144 Vietnam: Asean Point of Care Diagnostics Market, by Technology, 2022-2030 (USD Million)
Table 145 Vietnam: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Technology, 2022-2030 (USD Million)
Table 146 Vietnam: Asean Point of Care Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 147 Singapore: Macroeconomic Indicators for Asean Point of Care Diagnostics Market
Table 148 Singapore: Asean Point of Care Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 149 Singapore: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Disease Type, 2022-2030 (USD Million)
Table 150 Singapore: Asean Point of Care Diagnostics Market for Respiratory Infection Testing Products, by Type, 2022-2030 (USD Million)
Table 151 Singapore: Asean Point of Care Diagnostics Market for Hepatitis Testing Products, by Type, 2022-2030 (USD Million)
Table 152 Singapore: Asean Point of Care Diagnostics Market for Glucose Monitoring Products, by Type, 2022-2030 (USD Million)
Table 153 Singapore: Asean Point of Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2022-2030 (USD Million)
Table 154 Singapore: Asean Point of Care Diagnostics Market, by Technology, 2022-2030 (USD Million)
Table 155 Singapore: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Technology, 2022-2030 (USD Million)
Table 156 Singapore: Asean Point of Care Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 157 Myanmar: Macroeconomic Indicators for Asean Point of Care Diagnostics Market
Table 158 Myanmar: Asean Point of Care Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 159 Myanmar: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Disease Type, 2022-2030 (USD Million)
Table 160 Myanmar: Asean Point of Care Diagnostics Market for Respiratory Infection Testing Products, by Type, 2022-2030 (USD Million)
Table 161 Myanmar: Asean Point of Care Diagnostics Market for Hepatitis Testing Products, by Type, 2022-2030 (USD Million)
Table 162 Myanmar: Asean Point of Care Diagnostics Market for Glucose Monitoring Products, by Type, 2022-2030 (USD Million)
Table 163 Myanmar: Asean Point of Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2022-2030 (USD Million)
Table 164 Myanmar: Asean Point of Care Diagnostics Market, by Technology, 2022-2030 (USD Million)
Table 165 Myanmar: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Technology, 2022-2030 (USD Million)
Table 166 Myanmar: Asean Point of Care Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 167 Cambodia: Macroeconomic Indicators for Asean Point of Care Diagnostics Market
Table 168 Cambodia: Asean Point of Care Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 169 Cambodia: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Disease Type, 2022-2030 (USD Million)
Table 170 Cambodia: Asean Point of Care Diagnostics Market for Respiratory Infection Testing Products, by Type, 2022-2030 (USD Million)
Table 171 Cambodia: Asean Point of Care Diagnostics Market for Hepatitis Testing Products, by Type, 2022-2030 (USD Million)
Table 172 Cambodia: Asean Point of Care Diagnostics Market for Glucose Monitoring Products, by Type, 2022-2030 (USD Million)
Table 173 Cambodia: Asean Point of Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2022-2030 (USD Million)
Table 174 Cambodia: Asean Point of Care Diagnostics Market, by Technology, 2022-2030 (USD Million)
Table 175 Cambodia: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Technology, 2022-2030 (USD Million)
Table 176 Cambodia: Asean Point of Care Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 177 Laos: Macroeconomic Indicators for Asean Point of Care Diagnostics Market
Table 178 Laos: Asean Point of Care Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 179 Laos: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Disease Type, 2022-2030 (USD Million)
Table 180 Laos: Asean Point of Care Diagnostics Market for Respiratory Infection Testing Products, by Type, 2022-2030 (USD Million)
Table 181 Laos: Asean Point of Care Diagnostics Market for Hepatitis Testing Products, by Type, 2022-2030 (USD Million)
Table 182 Laos: Asean Point of Care Diagnostics Market for Glucose Monitoring Products, by Type, 2022-2030 (USD Million)
Table 183 Laos: Asean Point of Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2022-2030 (USD Million)
Table 184 Laos: Asean Point of Care Diagnostics Market, by Technology, 2022-2030 (USD Million)
Table 185 Laos: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Technology, 2022-2030 (USD Million)
Table 186 Laos: Asean Point of Care Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 187 Brunei: Macroeconomic Indicators for Asean Point of Care Diagnostics Market
Table 188 Brunei: Asean Point of Care Diagnostics Market, by Product, 2022-2030 (USD Million)
Table 189 Brunei: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Disease Type, 2022-2030 (USD Million)
Table 190 Brunei: Asean Point of Care Diagnostics Market for Respiratory Infection Testing Products, by Type, 2022-2030 (USD Million)
Table 191 Brunei: Asean Point of Care Diagnostics Market for Hepatitis Testing Products, by Type, 2022-2030 (USD Million)
Table 192 Brunei: Asean Point of Care Diagnostics Market for Glucose Monitoring Products, by Type, 2022-2030 (USD Million)
Table 193 Brunei: Asean Point of Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2022-2030 (USD Million)
Table 194 Brunei: Asean Point of Care Diagnostics Market, by Technology, 2022-2030 (USD Million)
Table 195 Brunei: Asean Point of Care Diagnostics Market for Infectious Disease Testing Products, by Technology, 2022-2030 (USD Million)
Table 196 Brunei: Asean Point of Care Diagnostics Market, by End-user, 2022-2030 (USD Million)
Table 197 Overview of Strategies Deployed by Key Companies in Asean Point of Care Diagnostics Market, January 2021-March 2025
Table 198 Asean Point of Care Diagnostics Market: Degree of Competition
Table 199 Asean Point of Care Diagnostics Market: Country Footprint
Table 200 Asean Point of Care Diagnostics Market: Product Footprint
Table 201 Asean Point of Care Diagnostics Market: Technology Footprint
Table 202 Asean Point of Care Diagnostics Market: Detailed List of Key Startups/SMEs
Table 203 Asean Point of Care Diagnostics Market: Competitive Benchmarking of Key Startups/SMEs, by Technology
Table 204 Asean Point of Care Diagnostics Market: Competitive Benchmarking of Key Startups/SMEs, by Country
Table 205 Asean Point of Care Diagnostics Market: Product Launches & Approvals, January 2021-March 2025
Table 206 Asean Point of Care Diagnostics Market: Deals, January 2021-March 2025
Table 207 Asean Point of Care Diagnostics Market: Expansions, January 2021-March 2025
Table 208 Abbott: Company Overview
Table 209 Abbott: Products Offered
Table 210 Abbott: Product Approvals, January 2021-March 2025
Table 211 Abbott: Deals, January 2021- March 2025
Table 212 F. Hoffmann-La Roche Ltd.: Company Overview
Table 213 F. Hoffmann-La Roche Ltd.: Products Offered
Table 214 F. Hoffmann-La Roche Ltd.: Product Launches & Approvals, January 2021-March 2025
Table 215 F. Hoffmann-La Roche Ltd.: Deals, January 2021- March 2025
Table 216 Siemens Healthineers AG: Company Overview
Table 217 Siemens Healthineers AG: Products Offered
Table 218 Siemens Healthineers AG: Product Approvals, January 2021-March 2025
Table 219 Siemens Healthineers AG: Deals, January 2021- March 2025
Table 220 Siemens Healthineers AG: Expansions, January 2021- March 2025
Table 221 Sysmex Corporation: Company Overview
Table 222 Sysmex Corporation: Products Offered
Table 223 Sysmex Corporation: Expansions, January 2021-March 2025
Table 224 Danaher Corporation: Company Overview
Table 225 Danaher Corporation: Products Offered
Table 226 Bd: Company Overview
Table 227 Bd: Products Offered
Table 228 Bd: Deals, January 2021-March 2025
Table 229 Bd: Expansions, January 2021-March 2025
Table 230 Quidelortho Corporation: Company Overview
Table 231 Quidelortho Corporation: Products Offered
Table 232 Quidelortho Corporation: Product Approvals, January 2021-March 2025
Table 233 Quidelortho Corporation: Deals, January 2021-March 2025
Table 234 Quidelortho Corporation: Expansions, January 2021-March 2025
Table 235 Cardinal Health: Company Overview
Table 236 Cardinal Health: Products Offered
Table 237 Cardinal Health: Deals, January 2021-March 2025
Table 238 Cardinal Health: Expansions, January 2021-March 2025
Table 239 Biomérieux: Company Overview
Table 240 Biomérieux: Products Offered
Table 241 Biomérieux: Product Approvals, January 2021-March 2025
Table 242 Biomérieux: Deals, January 2021-March 2025
Table 243 Ekf Diagnostics Holdings PLC: Company Overview
Table 244 Ekf Diagnostics Holdings PLC: Products Offered
Table 245 Ekf Diagnostics Holdings PLC: Product Launches, January 2021-March 2025
Table 246 Ekf Diagnostics Holdings PLC: Deals, January 2021-March 2025
Table 247 Ekf Diagnostics Holdings PLC: Expansions, January 2021-March 2025
Table 248 Thermo Fisher Scientific Inc.: Company Overview
Table 249 Thermo Fisher Scientific Inc.: Products Offered
Table 250 Thermo Fisher Scientific Inc.: Product Launches, January 2021-March 2025
Table 251 Thermo Fisher Scientific Inc.: Deals, January 2021-March 2025
Table 252 Accubiotech Co. Ltd.: Company Overview
Table 253 Accubiotech Co. Ltd.: Products Offered
Table 254 Accubiotech Co. Ltd.: Product Approvals, January 2021-March 2025
Table 255 Biosynex SA: Company Overview
Table 256 Sd Biosensor, Inc.: Company Overview
Table 257 Sekisui Diagnostics: Company Overview
Table 258 Werfen: Company Overview
Table 259 Trinity Biotech: Company Overview
Table 260 Pts Diagnostics: Company Overview
Table 261 Lifescan IP Holdings, LLC: Company Overview
Table 262 Ctk Biotech, Inc.: Company Overview
Table 263 Wondfo: Company Overview
Table 264 Arkray, Inc.: Company Overview
Table 265 Xiamen Boson Biotech Co. Ltd.: Company Overview
Table 266 Credo Diagnostics Biomedical Pte. Ltd.: Company Overview
Table 267 Anbio Biotechnology Inc.: Company Overview
Table 268 Sg Diagnostics: Company Overview

Figure 1 Markets Covered & Regions Considered
Figure 2 Asean Point of Care Diagnostics Market: Research Design
Figure 3 Asean Point of Care Diagnostics Market: Key Industry Insights
Figure 4 Breakdown of Primary Interviews: Supply- and Demand-Side Participants
Figure 5 Breakdown of Primary Interviews: by Company Type and Designation
Figure 6 Bottom-Up Approach: Company Revenue Estimation Approach
Figure 7 CAGR Projections: Supply-Side Analysis
Figure 8 Asean Point of Care Diagnostics Market: Top-Down Approach
Figure 9 Asean Point of Care Diagnostics Market: Data Triangulation Methodology
Figure 10 Asean Point of Care Diagnostics Market: Research Assumptions
Figure 11 Asean Point of Care Diagnostics Market, by Product, 2025 vs. 2030 (USD Million)
Figure 12 Asean Point of Care Diagnostics Market, by Technology, 2025 vs. 2030 (USD Million)
Figure 13 Asean Point of Care Diagnostics Market, by End-user, 2025 vs. 2030 (USD Million)
Figure 14 Asean Point of Care Diagnostics Market, by Country, 2025 vs. 2030 (USD Million)
Figure 15 Rising Prevalence of Infectious Diseases to Propel Market
Figure 16 Glucose Monitoring Products Segment to Dominate Market During Forecast Period
Figure 17 Biochemistry Segment to Hold Largest Market Share Till 2030
Figure 18 Home Care Settings and Clinical Laboratories to Account for Major Market Shares During Forecast Period
Figure 19 Vietnam to Register Highest Growth During Forecast Period
Figure 20 Asean Point of Care Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Estimates of Tb Incidence for Southeast Asia Region, by Age Group and Gender (2023)
Figure 22 Asean Point of Care Diagnostics Market: Trends/Disruptions Impacting Customers’ Businesses
Figure 23 Asean Point of Care Diagnostics Market: Value Chain Analysis
Figure 24 Asean Point of Care Diagnostics Market: Supply Chain Analysis
Figure 25 Asean Point of Care Diagnostics Market: Ecosystem Analysis
Figure 26 Investment & Funding Scenario, 2021-2024
Figure 27 Asean Point of Care Diagnostics Market: Patent Analysis, January 2014-December 2024
Figure 28 Asean Point of Care Diagnostics Market: Porter's Five Forces Analysis
Figure 29 Influence of Stakeholders on Buying Process, by Technology
Figure 30 Key Buying Criteria, by Technology
Figure 31 Asean Point of Care Diagnostics Market: Potential of AI
Figure 32 Asean: Point of Care Diagnostics Market Snapshot
Figure 33 Revenue Analysis of Key Players in Asean Point of Care Diagnostics Market, 2022-2024
Figure 34 Market Share Analysis of Key Players in Asean Point of Care Diagnostics Market, 2024
Figure 35 Asean Point of Care Diagnostics Market: Company Evaluation Matrix (Key Players), 2024
Figure 36 Asean Point of Care Diagnostics Market: Company Footprint
Figure 37 Asean Point of Care Diagnostics Market: Company Evaluation Matrix (Startups/SMEs), 2024
Figure 38 EV/Ebitda of Key Vendors, 2025
Figure 39 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of Key Vendors, 2025
Figure 40 Asean Point of Care Diagnostics Market: Brand/Product Comparison Matrix
Figure 41 Abbott: Company Snapshot (2024)
Figure 42 F. Hoffmann-La Roche Ltd.: Company Snapshot (2024)
Figure 43 Siemens Healthineers AG: Company Snapshot (2024)
Figure 44 Sysmex Corporation: Company Snapshot (2023)
Figure 45 Danaher Corporation: Company Snapshot (2024)
Figure 46 Bd: Company Snapshot (2024)
Figure 47 Quidelortho Corporation: Company Snapshot (2024)
Figure 48 Cardinal Health: Company Snapshot (2024)
Figure 49 Biomérieux: Company Snapshot (2024)
Figure 50 Ekf Diagnostics Holdings PLC: Company Snapshot (2023)
Figure 51 Thermo Fisher Scientific Inc.: Company Snapshot (2024)